Renee Cottle

Renee Cottle is an Associate Professor in the Department of Bioengineering at Clemson University. She holds a Ph.D. in Biomedical Engineering from Georgia Institute of Technology and Emory University (2015). Her research focuses on developing cell-based gene therapy technologies and point-of-care diagnostic tools for inherited metabolic diseases, integrating life sciences and bioengineering principles. Key areas include CRISPR-Cas9 gene editing, ex vivo hepatocyte modification, and 3D culture systems for disease modeling.

Education: Ph.D. in Biomedical Engineering, Georgia Tech & Emory University (2015).

Research interests emphasize genome editing, targeted therapies, and translational biomedical devices. Techniques include off-target analysis via next-gen sequencing, lipid nanoparticle delivery, and functionalized scaffold-based systems. The Cottle Group also prioritizes training future bioengineers through research, professional development, and community outreach.

Lab/Team: The Cottle Group operates within the Department of Bioengineering, advancing therapies and diagnostics for metabolic disorders. Their work includes developing amino acid monitoring devices and in vitro disease models for drug screening.